EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
Jaguar Animal Health, Inc. (JAGX) had EBITDA Margin of -378.36% for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$11.51M |
|
$-53.58M |
|
$3.77M |
|
$7.74M |
|
$57.42M |
|
$-45.91M |
|
$-8.09M |
|
$-54.00M |
|
$-54.00M |
|
$-54.00M |
|
$-54.00M |
|
$-54.00M |
|
$-54.00M |
|
$-45.91M |
|
$-43.55M |
|
2.33M |
|
2.33M |
|
$-22.97 |
|
$-22.97 |
|
| Balance Sheet Financials | |
$20.34M |
|
$0.46M |
|
$17.98M |
|
$38.32M |
|
$40.65M |
|
$15.08M |
|
$16.36M |
|
$57.01M |
|
$-21.17M |
|
$-34.71M |
|
$-18.69M |
|
6.98M |
|
| Cash Flow Statement Financials | |
$-23.69M |
|
$-0.04M |
|
$23.67M |
|
$8.00M |
|
$7.83M |
|
$-0.17M |
|
$0.83M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.50 |
|
-- |
|
-- |
|
-4.18 |
|
-2.28 |
|
67.21% |
|
-398.82% |
|
-398.82% |
|
|
EBITDA Margin |
-378.36% |
-469.09% |
|
-465.42% |
|
$-23.73M |
|
-- |
|
-- |
|
-- |
|
0.30 |
|
0.44 |
|
6.78 |
|
53.84 |
|
255.03% |
|
155.57% |
|
-140.90% |
|
1497.84% |
|
$-2.68 |
|
$-10.17 |
|
$-10.16 |
|